Cancer drug resistance as a temporal process: cell plasticity, adaptive buffering, signaling pathways and therapeutic interception.

Iborra FJ, Martí C, Calabuig-Navarro V, Papadopoulos P, Iborra PM, Fons AC, Martínez-Lorente A, Almazán F, Calabuig J

Open source

DOI
10.1038/s41392-026-03106-4
Published
2026 Nov 10
Container
Signal transduction and targeted therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-026-03106-4,
  title = {Cancer drug resistance as a temporal process: cell plasticity, adaptive buffering, signaling pathways and therapeutic interception.},
  author = {Iborra FJ and Martí C and Calabuig-Navarro V and Papadopoulos P and Iborra PM and Fons AC and Martínez-Lorente A and Almazán F and Calabuig J},
  year = {2026},
  journal = {Signal transduction and targeted therapy},
  doi = {10.1038/s41392-026-03106-4},
  url = {https://doi.org/10.1038/s41392-026-03106-4}
}

RIS

TY  - JOUR
TI  - Cancer drug resistance as a temporal process: cell plasticity, adaptive buffering, signaling pathways and therapeutic interception.
AU  - Iborra FJ
AU  - Martí C
AU  - Calabuig-Navarro V
AU  - Papadopoulos P
AU  - Iborra PM
AU  - Fons AC
AU  - Martínez-Lorente A
AU  - Almazán F
AU  - Calabuig J
PY  - 2026
JO  - Signal transduction and targeted therapy
DO  - 10.1038/s41392-026-03106-4
UR  - https://doi.org/10.1038/s41392-026-03106-4
ER  - 

APA

FJ, I., C, M., V, C., P, P., PM, I., AC, F., A, M., F, A., & J, C. (2026). Cancer drug resistance as a temporal process: cell plasticity, adaptive buffering, signaling pathways and therapeutic interception.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-026-03106-4

Source records